| Apos | Apolipoproteins |
| ASGPR1 | Asialoglycoprotein receptor 1 |
| BBB | Blood–brain barrier |
| BSA | Bovine serum albumin |
| CD44 | A cell-surface glycoprotein involved in cell–cell interactions |
| CT | Computer tomography |
| CXCR4 | C-X-C motif chemokine receptor 4 |
| DDS | Drug delivery system |
| FR | Folate receptor |
| GLUT-1 | Glucose transporter 1 |
| GPC-3 | Glypican-3 |
| GRP78 | 78 kDa glucose-regulated protein, heat shock protein |
| HA | Hyaluronic acid |
| HCC | Hepatocellular carcinoma |
| iRGD | Cyclic peptide, ligand of neuropilin-1 |
| LDLR | Low-density lipoprotein receptor |
| MRI | Magnetic resonance imaging |
| NP | Nanoparticle |
| NP-1 | Neuropilin-1 |
| PCL | Polycaprolactone |
| PEO | Poly(ethylene oxide) |
| PLC | Primary liver cancer |
| PLGA | Poly(lactic-co-glycolic) acid |
| PVA | Poly(vinyl alcohol) |
| RGD | Arginine–glycine–aspartic |
| ROS | Reactive oxygen species |
| SI | Selectivity index |
| SOR | Sorafenib |
| SP94 | Peptide targeting GRP78 |
| TACE | Transarterial chemoembolization |
| TAE | Transarterial embolization |
| TPGS | Tocopherol polyethylene glycol succinate |